DXC

DXC Financing Cash Flow

-$786.00MTTM · USD

Period ending:

DXC FY Cash from FinancingUSD
DXC FY Cash from Financing1990-03-31: $27.60M1991-03-31: $6.40M1992-03-31: $259.90M1993-03-31: -$68.10M1994-03-31: $133.30M1995-03-31: $204.00M1996-03-31: $49.80M1997-03-31: $175.10M1998-03-31: $162.70M1999-03-31: $219.20M2000-03-31: -$111.35M2001-03-31: $1.32B2002-03-31: -$133.90M2003-03-31: -$20.20M2004-03-31: -$84.00M2005-03-31: -$900.60M2006-03-31: -$150.70M2007-03-31: -$955.50M2008-03-31: $997.90M2009-03-31: $742.10M2010-03-31: -$487.00M2011-03-31: -$1.68B2012-03-31: -$581.00M2013-03-31: -$589.00M2014-03-31: -$599.00M2015-03-31: -$1.04B2016-03-31: -$485.00M2017-03-31: $93.00M2018-03-31: -$1.89B2019-03-31: -$1.66B2020-03-31: $657.00M2021-03-31: -$5.48B2022-03-31: -$1.82B2023-03-31: -$1.51B2024-03-31: -$1.49B2025-03-31: -$317.00M2026-03-31: -$776.00M$1.32B-$5.48B
1990-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DXC financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 37 observations from Mar 31, 1990 to Mar 31, 2026.

DXC Technology Company Common Stock Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-776,000,000
-317,000,000
-1,487,000,000
-1,507,000,000
-1,818,000,000
-5,476,000,000
657,000,000
-1,663,000,000
-1,890,000,000
93,000,000
-485,000,000
-1,038,000,000
-599,000,000
-589,000,000
-581,000,000
-1,676,000,000
-487,000,000
742,100,000
997,900,000
-955,500,000
-150,700,000
-900,600,000
-84,000,000
-20,200,000
-133,900,000
1,321,500,000
-111,350,000
219,200,000
162,700,000
175,100,000
49,800,000
204,000,000
133,300,000
-68,100,000
259,900,000
6,400,000
27,600,000

Compare financing cash flow

All DXC financial metrics · DXC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.